The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

The global sleep apnea devices market is set to expand at a steady CAGR of 9.5%, growing from USD 8.2 billion in 2023 to USD ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

For patients with obstructive sleep apnea (OSA), sleep surgery is associated with a significantly reduced risk for mo ...

Tom Castaneda from South Texas Health Systems discusses Sleep apnea on the upcoming episode of STHS TV on NBC 23. This ...

Untreated sleep apnea contributes to car crashes. Patients who got no treatment were 21% more likely to be in a wreck than ...

Sleep apnea is a disorder that happens when your breathing is disrupted while you sleep. The condition affects sleep quality -- and it can also affect your pocketbook. An analysis by the American ...

How do you know which sleep apnea treatment is right for you? There are a number of ways to treat your symptoms and help you get a restful night’s sleep. Talk with your doctor before you try one.

A study reveals sleep apnea can cause brain damage, increasing risks of aging and dementia, particularly in Hispanic seniors.

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...

Her work has appeared in Women's Health, SELF, Prevention, The Washington Post, and more. Sleep apnea impacts about 30 million American adults, making it a common sleep disorder. But while plenty ...

The link between poor sleep and mental health problems could be related to deficits in brain regions that keep unwanted thoughts out of mind. The link between poor sleep and mental health problems ...